Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Study
  • Published:

Hypogonadotropism with elevated serum testosterone: reversible causes of secondary infertility

Abstract

Background A 33-year-old man presented with secondary infertility, increased libido, and extreme oligospermia. Testicular volumes were reduced, but no gynecomastia was apparent and androgen abuse was denied.

Investigations Physical examination, semen-volume and sperm-density assessment, laboratory tests for serum levels of luteinizing hormone, follicle-stimulating hormone, testosterone, and dehydroepiandrosterone sulfate, karyotyping, testicular ultrasound, pelvic and abdominal CT, assessment for serum testicular tumor markers (α-fetoprotein and human chorionic gonadotropin), and histologic examination of testicular tissue.

Diagnosis Benign Leydig-cell adenoma.

Management Left orchidectomy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The Leydig-cell tumor is characterized by typical Leydig cells, which show no unusual mitotic activity.
Figure 2: An algorithm for the investigation and management of the infertile male presenting with oligoazoospermia, suppressed serum gonadotropin levels, and no evidence of testicular tumor on clinical exmaination.

References

  1. Kim I et al. (1985) Leydig cell tumors of the testis. A clinicopathological analysis of 40 cases and review of the literature. Am J Surg Pathol 9: 177–192

    Article  CAS  Google Scholar 

  2. Liu G et al. (1999) Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N Engl J Med 341: 1731–1736

    Article  CAS  Google Scholar 

  3. Carvajal-Carmona LG et al. (2006) Adult leydig cell tumors of the testis caused by germline fumarate hydratase mutations. J Clin Endocrinol Metab 91: 3071–3075

    Article  CAS  Google Scholar 

  4. Caron PJ et al. (1994) Luteinizing hormone secretory pattern before and after removal of Leydig cell tumor of the testis. Eur J Endocrinol 131: 156–159

    Article  CAS  Google Scholar 

  5. Kuhn JM et al. (1994) Evidence of oestradiol-induced changes in gonadotrophin secretion in men with feminizing Leydig cell tumours. Eur J Endocrinol 131: 160–166

    Article  CAS  Google Scholar 

  6. Carmignani L et al. (2005) Prognostic parameters in adult impalpable ultrasonographic lesions of the testicle. J Urol 174: 1035–1038

    Article  Google Scholar 

  7. Fallick ML et al. (1999) Leydig cell tumors presenting as azoospermia. J Urol 161: 1571–1572

    Article  CAS  Google Scholar 

  8. Zhengwei Y et al. (1998) Stereological evaluation of human spermatogenesis after suppression by testosterone treatment: heterogeneous pattern of spermatogenic impairment. J Clin Endocrinol Metab 83: 1284–1291

    CAS  PubMed  Google Scholar 

  9. Mostafid H et al. (1998) Leydig cell tumour of the testis: a rare cause of male infertility. Br J Urol 81: 651

    Article  CAS  Google Scholar 

  10. Kuhn JM et al. (1987) Evaluation of diagnostic criteria for Leydig cell tumours in adult men revealed by gynaecomastia. Clin Endocrinol (Oxf) 26: 407–416

    Article  CAS  Google Scholar 

  11. Buckley WE et al. (1988) Estimated prevalence of anabolic steroid use among male high school seniors. JAMA 260: 3441–3445

    Article  CAS  Google Scholar 

  12. Death AK et al. (2004) Tetrahydrogestrinone is a potent androgen and progestin. J Clin Endocrinol Metab 89: 2498–2500

    CAS  Google Scholar 

  13. Gazvani MR et al. (1997) Conservative management of azoospermia following steroid abuse. Hum Reprod 12: 1706–1708

    Article  CAS  Google Scholar 

  14. Lefebvre H et al. (1993) A hCG-secreting testicular seminoma revealed by male infertility: mechanism of hCG-evoked endocrine disturbances. Andrologia 25: 283–287

    Article  CAS  Google Scholar 

  15. Stikkelbroeck NM et al. (2001) High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia. J Clin Endocrinol Metab 86: 5721–5728

    Article  CAS  Google Scholar 

  16. Kuhn JM et al. (2002) Cosecretion of estrogen and inhibin B by a feminizing adrenocortical adenoma: impact on gonadotropin secretion. J Clin Endocrinol Metab 87: 2367–2375

    Article  CAS  Google Scholar 

  17. Akman H et al. (2003) Incidental bilateral leydig cell tumor of the testes. Urol Int 71: 316–318

    Article  Google Scholar 

  18. Steiner H et al. (2003) Frozen section analysis-guided organ-sparing approach in testicular tumors: technique, feasibility, and long-term results. Urology 62: 508–513

    Article  Google Scholar 

Download references

Acknowledgements

RI McLachlan is supported by an Australian National Health and Medical Research Council Fellowship #169020 and Program Grant #241000, DM de Kretser is supported by National Health and Medical Research Program Grant # 334011.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert I McLachlan.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McLachlan, R., de Kretser, D. Hypogonadotropism with elevated serum testosterone: reversible causes of secondary infertility. Nat Rev Urol 3, 560–565 (2006). https://doi.org/10.1038/ncpuro0585

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0585

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing